about
Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome.Combination Therapy in Fragile X Syndrome; Possibilities and Pitfalls Illustrated by Targeting the mGluR5 and GABA Pathway Simultaneously.Fragile X syndrome and fragile X-associated disorders.Of Men and Mice: Modeling the Fragile X Syndrome.Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome.Specificity: A Phenotypic Comparison of Communication-Relevant Domains Between Youth With Down Syndrome and Fragile X Syndrome
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Review of targeted treatments in fragile X syndrome
@ast
Review of targeted treatments in fragile X syndrome
@en
Review of targeted treatments in fragile X syndrome
@nl
type
label
Review of targeted treatments in fragile X syndrome
@ast
Review of targeted treatments in fragile X syndrome
@en
Review of targeted treatments in fragile X syndrome
@nl
prefLabel
Review of targeted treatments in fragile X syndrome
@ast
Review of targeted treatments in fragile X syndrome
@en
Review of targeted treatments in fragile X syndrome
@nl
P2860
P356
P1476
Review of targeted treatments in fragile X syndrome
@en
P2093
P2860
P304
P356
10.5582/IRDR.2016.01045
P407
P577
2016-08-01T00:00:00Z